Search by Title Article Topic - Any -AdvocacyCertificationClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure AwarenessHeart Failure GuidelinesHFSA Annual Scientific MeetingHFSA AwardsHFSA Board Certification ReviewHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterHFSA MembershipIn The NewsIndustryJournal of Cardiac FailureMentorshipNursingPartnersPatient ResourcePodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Nov 1 2020 | HFSA President's Update: November 2020 HFSA News President's Updates Read More Oct 30 2020 | PhRMA Foundation Launches Valuing Health Equity Challenge Award Practice News In The News Read More Oct 27 2020 | New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status Industry News Industry Read More Oct 20 2020 | New HFSA Resources on Disparities in Heart Failure Now Available HFSA News Heart Failure Awareness Provider Education Read More Oct 13 2020 | Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure Industry News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last »
Oct 30 2020 | PhRMA Foundation Launches Valuing Health Equity Challenge Award Practice News In The News Read More
Oct 27 2020 | New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status Industry News Industry Read More
Oct 20 2020 | New HFSA Resources on Disparities in Heart Failure Now Available HFSA News Heart Failure Awareness Provider Education Read More
Oct 13 2020 | Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure Industry News Industry Read More
